Carlsbad, CA and Copenhagen, Denmark – August 30, 2018: The 24th annual BIO-Europe® 2018 global life science partnering event will be held November 5–7, 2018, in Copenhagen, Denmark, part of Medicon Valley, the leading life science cluster in Scandinavia, supported by regional hosts Copenhagen Capacity, Invest in Skåne, LEO Pharma, Lundbeck Fonden, Novo Holdings, Novo Nordisk and Novozymes. The event is expected to bring together over 4,000 executives from 2,200+ life science companies spanning an estimated 60+ countries to engage in one-to-one partnering.
“This is the first time that Europe’s biggest biotech conference will visit Scandinavia, and as a life science professional, I am certain EBD Group has chosen the right location,” said Søren Bregenholt, chairman of the Danish-Swedish life science cluster organization, Medicon Valley Alliance. “Whether you are looking for a new startup to invest in, a collaboration partner or new exciting science, I am sure you will find Copenhagen, and Medicon Valley, an exciting and rewarding place to visit, explore and do business.”
“We are pleased to be hosted by this world-renowned group of Medicon Valley companies to bring BIO-Europe to Copenhagen for the first time,” said Anna Chrisman, Group Managing Director, EBD Group. “This biopharma cluster is one of Europe’s leading life sciences hubs, with 23 life science parks and incubators, over 350 biotech, medtech and pharma companies, and groundbreaking research in unmet medical needs, making it the perfect setting for the deal making and discovery that takes place at BIO-Europe to further global drug development.”
BIO-Europe is a “must-attend” event for executives from the global biotechnology industry who will gain direct access to service and manufacturing partners, innovative assets, and ideas from biotech companies ranging from very early stage to large, established companies. The event is also a critical business strategy for biotech companies to meet with pharma executives and investors to propel their drug development commercialization goals.
BIO-Europe 2017 broke records for number of delegates and number of one-to-one partnering meetings which reached an all-time high of 24,200, powered by EBD’s industry-leading platform, partneringONE. CEOs and decision makers from 2,199 companies discussed asset deals and strategic collaborations. There were 5,142 licensing opportunities on offer, 152 company presentations and 106 exhibitors.
Register for BIO-Europe 2018 before August 31, 2018, and save EUR 200 off the regular registration rate.
For news and interviews with executives and thought leaders in the life science industry, go to EBD Group’s Partnering Insight.
# # #
Additional links and information:
Follow BIO-Europe 2018 on Twitter: @EBDGroup (hashtag: #BIOEUROPE).
About EBD Group
EBD Group’s overriding mission is to help collaborations get started across the life science value chain. Our range of partnering conferences has grown to become the largest and most productive conference platform in the industry. Each one of our landmark events held in key life science markets around the world is powered by our state-of-the-art partnering software, partneringONE®, that enables delegates to efficiently identify and engage with new opportunities via one-to-one meetings.
Today our events (BIO-Europe®, BIO-Europe Spring®, BioPharm America™, Biotech Showcase™, BioEquity Europe, ChinaBio® Partnering Forum, Cell & Gene Connect, and Digital Medicine & Medtech Showcase) annually attract more than 15,000 senior life science executives who engage in over 50,000 one-to-one partnering meetings. These vital one-to-one engagements are the wellspring of deals that drive innovation in our industry.
Tune into EBD Group’s Partnering Insight for timely coverage of news that influences the business strategies of the life science industry. EBD Group is an Informa company. For more information please visit www.ebdgroup.com.
Kari Bennett, EBD Group: +1 760 930 0500; firstname.lastname@example.org
European media support
Anne Hennecke, MC Services AG: +49 211 529 252 22; email@example.com